Can you provide the upcoming earnings date for BIOAFFINITY TECHNOLOGIES INC?
BIOAFFINITY TECHNOLOGIES INC (BIAF) will report earnings on 2026-04-06.
BIOAFFINITY TECHNOLOGIES INC (BIAF) Forecast, Price Target & Analyst Ratings
NASDAQ:BIAF • US09076W3079
Current stock price
2.28 USD
-0.46 (-16.79%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BIOAFFINITY TECHNOLOGIES INC (BIAF).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Apr 6, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$2.75
- Revenue Estimate
- 1.584M
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $2.28 to mean target of N/A, Based on 6 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
43.33%
BIAF was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about BIAF.
In the previous month the buy percentage consensus was at a similar level.
BIAF was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-04-01 | Maxim Group | Downgrade | Buy -> Hold |
| 2024-07-23 | Maxim Group | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Apr 6, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$2.75
- Revenue Estimate
- 1.584M
- Revenue Q2Q
- -28.26%
- EPS Q2Q
- 56.29%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
BIAF is expected to report earnings on 4/6/2026. The consensus EPS estimate for the next earnings is -2.75 USD and the consensus revenue estimate is 1.58M USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.533M | 9.362M 269.67% | 6.209M -33.68% | 7.453M 20.04% | ||
| EBITDA YoY % growth | -4M -81.00% | -7.724M -93.09% | -8.348M -8.08% | N/A | N/A | |
| EBIT YoY % growth | -4.01M -81.45% | -7.973M -98.83% | -8.954M -12.29% | -11.008M -22.94% | -11.285M -2.52% | |
| Operating Margin | N/A | -314.84% | -95.64% | -177.29% | -151.42% | |
| EPS YoY % growth | N/A | N/A 56.70% | N/A 2.38% | -14.69 41.46% | -8.26 43.75% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -2.75 56.29% | -2.45 49.00% | -2.14 58.00% | -2.14 54.81% |
| Revenue Q2Q % growth | 1.584M -28.26% | 1.513M -18.38% | 1.735M 36.72% | 1.943M 34.37% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -2.973M -0.91% | -3.088M -17.53% | -2.69M -6.92% | -2.765M -20.60% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
BIOAFFINITY TECHNOLOGIES INC / BIAF Forecast FAQ
What are the consensus estimates for BIAF stock next earnings?
The consensus EPS estimate for the next earnings of BIOAFFINITY TECHNOLOGIES INC (BIAF) is -2.75 USD and the consensus revenue estimate is 1.58M USD.
What is the consensus rating for BIAF stock?
The consensus rating for BIOAFFINITY TECHNOLOGIES INC (BIAF) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.